Silicon Canals
TRENDING
  • Mobility
  • AI
  • FinTech
  • Software & SaaS
No Result
View All Result
  • Home
  • News
    • COVID-19
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Features
    • Promoted content
    • How-to
    • Knowledge & Insights
    • Guest Contributions
    • Scaling-up in Europe
  • Amsterdampartner
  • Events
  • Newsletter
  • Jobs
  • About
    • Partner with Silicon Canals
    • Team
    • Contact
  • Home
  • News
    • COVID-19
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Features
    • Promoted content
    • How-to
    • Knowledge & Insights
    • Guest Contributions
    • Scaling-up in Europe
  • Amsterdampartner
  • Events
  • Newsletter
  • Jobs
  • About
    • Partner with Silicon Canals
    • Team
    • Contact
No Result
View All Result
Silicon Canals
No Result
View All Result

Dutch startup Orikami receives €600K investment from Healthy Capital

Akansha Srivastava by Akansha Srivastava
October 9, 2019
in News, (Crowd)funding, Health & Medtech, Startups
0
Dutch startup Orikami receives €600K investment from Healthy Capital
82
SHARES
LinkedInTwitterWhatsAppFacebook

Healthcare is undergoing a major technological transformation, and it is wise for the industry to leverage new and innovative tech to generate track novel data. Accumulation of data helps researchers, entrepreneurs, clinicians, and consumers to better understand both health and disease. In this case, digital biomarkers act as an opportunity to interpret new data sources into informative, actionable insights.

Based out of Nijmegen, Orikami is changing the world with smart algorithms by creating and deploying digital biomarkers that can make health care both more personal and more affordable. Patients get quicker access to effective treatment, leading to reduced waste and better treatment outcomes. Healthy.Capital’s investment will help Orikami offer personalised care to its first 25,000 patients.

 - Partner content -
Cost of software - The Software house
The cost of building software
Marek Gajda, CTO of The Software House, shares his insights on building high-quality...Show More
Marek Gajda, CTO of The Software House, shares his insights on building high-quality software. Show Less
Read more

Personalised health care is crucial to continue increasing patients’ quality of life while keeping health care affordable. Yet doctors and pharmaceutical companies face numerous challenges delivering treatments that cater to individual patients. Healthy.Capital is investing €600,000 to help Orikami grow and accelerate.

Orikami personalises health care using medically validated artificial intelligence software to translate patient data into digital treatment support called digital biomarkers. These biomarkers help medical specialists prescribe medication effectively, improving treatment and reducing wasted time and costs related to ineffective and often expensive treatments.

Multiple Sclerosis patients, for example, can monitor their condition using Orikami’s MS Sherpa app to see if their medication has the desired effect. In the case of Fampyra, an MS medication that has been at the center of political discussions, the Dutch Health Minister recently decided that the medication could only be used if it is proven to be effective within two weeks. In the future, an Orikami developed algorithm could help doctors measure a medication’s effectiveness from a distance.

Bram den Teuling, founder of Orikami, said:

Recognising data patterns by continually monitoring the patient delivers insights that help when it comes to offering customised medical treatments. Our information is used to make important decisions and therefore it’s crucial that our products are clinically validated and certified. The past five years have given us significant experience with those processes. That makes us unique in the market. We are also actively looking for new collaborations with pharmaceutical companies.

Artificial intelligence plus health care equals better yields for society.

Orikami’s strategic strength lies in the choice to bundle their digital biomarkers in a platform. The digital biomarkers for both walking speed and cognition speed can be used for several chronic illnesses. At the moment, many pharmaceutical companies and hospitals are reinventing the wheel in disparate digital health initiatives. This has resulted in tremendous fragmentation in a small country like the Netherlands. In 2020, new laws that will require serious investments in quality management systems will separate the wheat from the chaff. Orikami is ready for these changes and their certified platform can significantly reduce the time to market and investment costs.

 Douwe Jippes, managing partner at Healthy.Capital, said:

Digital biomarkers are the basis for moving towards more personalised health care. Orikami is the leader in Europe when it comes to the development of validated digital biomarkers. After an in-depth analysis of the European sector, one proposition stood out head and shoulders above the rest; Orikami.

 Investing for growth

The Healthy.Capital investment should further accelerate Orikami’s already impressive growth and will be used to facilitate the launch of the digital biomarker platform and MS Sherpa.

Stay tuned to Silicon Canals for more European technology news.

World Summit AI 2019 is back, here’s how you can get a 20% discount

 

close

Want to stay on top of the latest rounds, coolest tech and hottest startups?

Subscribe to our free, daily news blast and stay up-to-date!

Check your inbox or spam folder to confirm your subscription.

 - Partner content -
Hiring during COVID Intrinsic Search
Hiring SaaS sales executives
Check out the do's and don'ts while hiring SaaS sales executives
Check out the do's and don'ts while hiring SaaS sales executives Show Less
Read more
Tags: Dutch Startupsfundingmedtech
Share2Tweet7SendShare65

Partner content | Work with us

Future of coding: CTOs discuss low-code versus custom code software development for their business

Why now is the perfect time to start hiring for 2021

SaaS sales in 2021: 9 predictions from an industry expert

Diversity in hiring for SaaS: the often overlooked topic of ageism

Boost your scale-up’s growth by outsourcing to these top Eastern European software development companies

Subscribe to our daily newsletter

Check your inbox or spam folder to confirm your subscription.

Breaking news from Amsterdam | Partner

Meet the 10 Dutch scaleups selected by Amsterdam-based Techleap.nl for Rise Programme 2021

Amsterdam-based 3D Hubs acquired by Protolabs for €272.1M; here’s what you need to know

Amsterdam-based INKEF Capital leads €5M Series A funding round of this Dutch startup

4 experts predict what 2021 might hold for the startup ecosystem of Amsterdam

Advertisement

Trending

3D Hubs
Amsterdam

Amsterdam-based 3D Hubs acquired by Protolabs for €272.1M; here’s what you need to know

January 19, 2021
Amsterdam
Amsterdam

9 promising sustainable startups from Amsterdam to watch in 2021

January 20, 2021
BUX
News

The crypto platform of Amsterdam fintech BUX witnesses “explosive growth” as Bitcoin remains popular

January 22, 2021
  • About Silicon Canals
  • Partner with Silicon Canals
  • Contact us
  • Newsletter
  • Disclaimer
  • Privacy policy
  • Terms & Conditions Silicon Canals

Silicon Canals 2014-2020 | Website: Bright Idiots

No Result
View All Result
  • Home
  • News
    • COVID-19
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Features
    • Promoted content
    • How-to
    • Knowledge & Insights
    • Guest Contributions
    • Scaling-up in Europe
  • Amsterdam
  • Events
  • Newsletter
  • Jobs
  • About
    • Partner with Silicon Canals
    • Team
    • Contact

Silicon Canals 2014-2020 | Website: Bright Idiots

X

This website uses cookies to ensure the best possible experience. We may share this information with our advertising and analytics partners. By clicking 'Accept', you agree to our use of cookies and similar technologies. More info